Breaking News
Subscribe Now 0
💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair Value See Undervalued Stocks

Stock Markets Analysis & Opinion

Contribute
Edison
VolitionRx: Big EU Trials On Deck   By Edison - Nov 29, 2017

In September 2017, Volitionrx Ltd (NYSE:VNRX) announced its European development plan for the Nu.Q™ colorectal cancer (CRC) frontline screening test. It will run two clinical trials (of 4,300...

Continue with Apple
Continue with Google
or
Sign up with Email